Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-10
Closed -$2K 5998
2021
Q1
$2K Sell
10
-16
-62% -$5.38K ﹤0.01% 4942
2020
Q4
$9K Hold
26
﹤0.01% 3269
2020
Q3
$8K Hold
26
﹤0.01% 3148
2020
Q2
$5K Buy
+26
New +$11.3K ﹤0.01% 3309
2019
Q1
Sell
-7
Closed -$1K 4365
2018
Q4
$1K Buy
+7
New +$2.9K ﹤0.01% 3624
2018
Q3
Sell
-11
Closed -$1K 4377
2018
Q2
$1K Hold
11
﹤0.01% 3835
2018
Q1
$1K Buy
11
+4
+57% +$1.92K ﹤0.01% 4056
2017
Q4
$1K Buy
+7
New +$3.97K ﹤0.01% 4473
2016
Q1
Sell
-4
Closed -$37K 6801
2015
Q4
$37K Buy
+4
New +$20.5K ﹤0.01% 2782

Other funds holding IMNN

Cutler Group's IMNN Position: Q4 2022 in Review

Cutler Group sold out of Imunon (IMNN) in Q4 2022, closing a stake of 8 shares.

Cutler Group first reported a position in IMNN in Q4 2015 and held it in 21 quarters. The position peaked at $44K in Q2 2020. 21 funds tracked by Wall St. Rank hold IMNN as of Q4 2022.

  • Cutler Group reported no remaining Imunon position as of Q4 2022 after selling out during the quarter.
  • Cutler Group sold 8 Imunon shares in Q4 2022.
  • Cutler Group first reported a position in Imunon in Q4 2015 and held it in 21 quarters.
  • Cutler Group's Imunon position peaked at $44K in Q2 2020.
  • 21 funds tracked by Wall St. Rank held Imunon as of Q4 2022.

Based on Cutler Group's 13F filing for Q4 2022, filed 7 Feb 2023.